Nephros, Inc. (NEPH)
4.775
-0.10
(-2.15%)
USD |
NASDAQ |
Jan 02, 16:00
4.775
0.00 (0.00%)
After-Hours: 17:51
Nephros Research and Development Expense (Annual): 0.906M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Apyx Medical Corp. | 5.08M |
| Owlet, Inc. | 9.801M |
| Perspective Therapeutics, Inc. | 39.33M |
| Xtant Medical Holdings, Inc. | 2.385M |
| VolitionRX Ltd. | 13.32M |